“Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 4, July 2025, p. s583, https://doi.org/10.25251/ed52rz19.